Arnall Golden Gregory LLP

Firm logo for Arnall Golden Gregory LLP

The eyelash wars – U.S. district court in California grants partial summary judgment to Allergan, finding that Athena Cosmetic’s revitalash eyelash growth products are unapproved new drugs in violation of California law

20/08/2012 Allergan, Inc. (Allergan) is the manufacturer and distributor of the approved drugs Latisse® to promote eyelash growth and Lumigan® for glaucoma.

Fair Credit Reporting Act - adverse action notice requirements for users of credit scores to take effect July 21, 2011

09/05/2011 Among the many changes enacted as a part of last year's Dodd-Frank Wall Street Reform and Consumer Protection Act (Public Law 111-209) (Dodd- Frank) is an amendment to the Fair Credit Reporting Act (FCRA), 15 U.

The “independent contractor” truck driver, wage & hour laws, the Affordable Care Act, and safety regulations

16/07/2015 On The challenges that trucking companies face regarding truck drivers continue to expand. One vexing issue facing many companies: Can they continue…

Do the new medical device registration requirements really apply to me?

09/01/2013 FDA has changed certain medical device establishment registration and listing requirements in accordance with the Medical Device User Fee Amendments…

Responding to the SEC comment letter

06/12/2012 Each year the staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (“SEC”) issues approximately 2,200 comment letters on the registration statements and reports filed under the Securities Act of 1933 and the Securities Exchange Act of 1934.

See more articles

Arnall Golden Gregory LLP


  • USA

    • Atlanta GA

      171 17th Street North West, Suite 2100, Atlanta GA 30363, USA
      T +1 404 873 8500F +1 404 873 8501[email protected]
    • Washington DC

      1775 Pennsylvania Avenue Northwest, Suite 1000, Washington DC 20006, USA
      T +1 202 677 4030F +1 202 677 4031